The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals
Rona J. Strawbridge, Keira J.A. Johnston, Mark E.S. Bailey, Damiano Baldassarre, Breda Cullen, Per Olof Eriksson, Ulf DeFaire, Amy Ferguson, Bruna Gigante, Philippe Giral, Nicholas Graham, Anders Hamsten, Steve Eric Humphries, Sudhir Kurl, Donald M. Lyall, , Daniel J. Smıth
The paper identifies metabolically distinct groups using genetic overlap between schizophrenia and cardiometabolic disease in two cohorts.
Scientific Reports · Jan 12, 2021Peer-reviewedGenetic & Genomic Medicine